#Journals

Deepti Gurdasani

dgurdasani1

Our paper in @TheLancet led by @ViolaPriesemann signed by >300 scientists calling for pan-European commitment to rapidly contain & maintain low SARS-CoV-2 levels through coordination. https://www.thelancet.com/journals/lancet/article

Julie Lynch

juliaflynch

Even more fun factoid: Political orientation varies a LOT by specialty. See comment below.https://twitter.com/WeedenKim/status/1347917090892689409 https://www.nytimes.com/2016/10/07/upshot/your-surgeon-is-probably-a-republican-your-psychiat

Kirsten Bibbins-Domingo

KBibbinsDomingo

Out today in @JAMAInternalMed our study led by @ch272n looking at excess mortality in CA in the first 6 months of the pandemic.Excess Mortality in California During the COVID-19 Pandemic,

Eric Feigl-Ding

DrEricDing

BREAKING—analysis of Russian #SARSCoV2 vaccine’s phase 3 trial with ~ 20,000 participants finds that a 2-dose regimen has an efficacy of 91.6% against symptomatic #COVID19. No serious adverse events were

Adam Sacarny

asacarny

a little thread on tips and tricks for working with the IRB when doing health economics and health services research. this is targeted at folks doing observational studies and interventions,

jd | love so overwhelming it is pouring out of him

turtle_sandbox

today i am thinking about [throws dart at list of "cool shit in clowntown"] smau authors' ingenuity in working within the confines of the medium (and even expanding past them!)let's

Roxana Daneshjou MD/PhD

RoxanaDaneshjou

Black and Brown dermatologists have been highlighting the disparities in dermatology education for decades, but general textbooks/journals and lectures are still lacking diversity. You can't be a "general" dermatologist if

Eric Meyerowitz, MD

EricMeyerowitz

1/ Thoughts on the exciting world of tocilizumab for treatment of COVID-19.RECOVERY tocilizumab preprint posted earlier today is another landmark paper and an enormous contribution to our expanding COVID-19 treatment

Mac n’ Chise 🧬🧫🦠

sailorrooscout

Let’s discuss SARS-CoV-2 variants, selective pressure, and mutations. In the face of variants, our best protection is to get more people vaccinated. Vaccination will not automatically select for vaccine-resistant variants,

The Public Archive

public_archive

All the white scholars and writers who have suddenly discovered race, racism, anti-racism, racial capitalism, and white supremacy need to figure out a reparative means of engaging with the Black

ASP_MirandaS, PharmD

ASP_MirandaS

Short on #medsafety #InfectiousDiseasesCame across an allergic reaction to meropenem described as "seizure".Turns out patient was on valproic acid (VPA) for seizure Rx. Started meropenem for suspected infection. "Allergy"

Network for Research into Chinese Ed Mobilities

ChiEdMobilities

A fascinating episode by four internally and transnationally #mobile Chinese academics @dikaioslin @chenchenzh @tingguowrites @andyhanlunli about their mobile trajectories and critical reflections on a wide range of issues. A must

Megan Ranney MD MPH 🗽

meganranney

Three new important studies came out in the past week about kids & #COVID19. All have limits (the science isn't perfect). But together, they matter, & you deserve to know

Lyman Stone 石來民

lymanstoneky

Henrik Kleven is out with a paper using 60 years of the entire population of Austria with a ton of family policy changes and he finds that childcare and parental

Prof Darrel Francis ☺ Mk CardioFellows Great Again

ProfDFrancis

Oooh a sizzler here, from the lab of John Spertus!Could it really be true that we PCI docs are telling porkie-pies about whether our patients have angina? Full story here:(Hat

Allen Cheng

peripatetical

SARS-CoV-2 infection in patients that don't have symptoms. It's complicated. A thread. Data suggest that viral load does start to increase and is maximal slightly before the onset of symptoms,

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.